Sign In | Create an Account | Welcome, . My Account | Logout | Subscribe | Submit News | Contact Us | Home RSS
 
 
 

New physician in town brings research aspect

June 29, 2010
By Jessica Huffman, Correspondent

Tiffin now is the home of a new general practice and medical research office. Dr. James Lassiter, nurse Pat Cox, research specialist Susie Frey and regulatory specialist Beth Kline are working with patients and study participants.

They will be conducting five studies over the next few months. The first one is a study to assess the effects of the arthritis medicines Celebrex, Motrin and Naproxen on the heart. It is sponsored by Cleveland Clinic and will be conducted over a four-year period. Study participants are to receive free medication, physicals, doctor visits and testing. They also are to receive compensation.

They will be starting two diabetic studies, an acne study, and a pain study over the next eight months.

"Research is fun," said Cox. "It's exciting to see a patient from beginning to end and to see results."

Lassiter has been practicing medicine for 20 years. He previously practiced at Upper Sandusky Hospital. He had a private OB/GYN practice, as well. He now is seeking patients and study participants.

Cox has been a nurse for 46 years. She has been involved in medical research ranging from osteoarthritis to diabetic hypertension. She has worked with doctors in Columbus and Upper Sandusky in general practice and medical research.

"It [the research process] makes me understand medicine better and why its so expensive," said Cox.

The office is located at 141 S. Monroe St. and will be open Monday through Thursday from 9 a.m. to 5 p.m.

 
 

 

I am looking for:
in:
News, Blogs & Events Web
 
 

Fact Box

Criteria for being part of arthritis study:

18 years of age or older.

Osteoarthritis or rheumatoid arthritis of at least six months' duration.

People who have required a chronic analgesic regimen for at least six months.

People who require and are eligible for long-term, daily nonsteroidal anti-inflammatory drug therapy to control the signs and symptoms of arthritis.

Established cardiovascular disease or high risk for the disease.

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures.

For more information, call (419) 443-1438.